CAV1 and pulmonary arterial hypertension: Frameshift mutations of CAV1 in PAH cases, revealed by functional analysis, can cause the mutant protein to retain in the endoplasmic reticulum, which is accompanied by the retention of wild-type protein morphology, and furthermore results in significant damage to cell membrane caveolae assembly (Copeland et al., 2017).